-
William Blair's Got Nerve: Initiates AxoGen Coverage With Outperform
Monday, February 5, 2018 - 5:31pm | 300Read More...AxoGen, Inc. (NASDAQ: AXGN) has no doubters. The 13-year-old nerve-repair company has wooed analysts of late and secured a new vote of confidence Monday with a sixth Buy rating. The Rating William Blair analysts Kaila Krum and Anna Nussbaum initiated coverage with an Outperform rating. The...
